[Gene therapy for Parkinson's disease].
Muramatsu
Shin-ichi
S
Division of Neurology, Department of Medicine, Jichi Medical School.
D000818:Animals; D001142:Aromatic-L-Amino-Acid Decarboxylases / Q000235:genetics / Q000627:therapeutic use; D000229:Dependovirus; D004298:Dopamine / Q000096:biosynthesis; D015316:Genetic Therapy / Q000379:methods / Q000639:trends; D005822:Genetic Vectors; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000235:genetics / Q000627:therapeutic use; D005968:Glutamate Decarboxylase / Q000235:genetics / Q000627:therapeutic use; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000378:metabolism / Q000628:therapy*
D051100:Glial Cell Line-Derived Neurotrophic Factor; D007527:Isoenzymes; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2; D001142:Aromatic-L-Amino-Acid Decarboxylases; D004298:Dopamine